Global Partnerships in Response to Antimicrobial Resistance: From Policy to Practice

Dear Colleagues,

Antimicrobial resistance (AMR) poses a critical threat to global health, disproportionally affecting low- and middle-income countries (LMICs) where health systems face infrastructure and resource constraints. While robust policy frameworks are essential, addressing AMR also requires actionable implementation through effective, real-word interventions and innovation.

This Special Issue aims to highlight the unique intersection of global health partnerships in AMR, with a particular focus on initiatives in LMICs—from strategic frameworks to on-the-ground impact.

We welcome contributions from professionals across the health sector—from academics, researchers, and policy makers to healthcare providers, implementers, and community health workers—sharing their practical experiences, innovations, and evidence-based solutions. Submissions may include original research, case-studies, and policy analyses that explore the design and implementation of AMR interventions, the influence of health partnerships, multidisciplinary, and collaborative work on national, regional, and local practices, and lessons learnt from global health initiatives.

By showcasing real-world solutions and fostering dialogue in the global health arena, this Special Issue aims to deepen understanding of how global health partnerships and collaborations drive sustainable progress, from policy to practice, for the contention of AMR.

Dr. Helena Rosado
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.